New biosensors aim to diagnose infections in minutes
NCT ID NCT06548841
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested two new types of biosensor platforms to detect viruses, bacteria, and parasites in blood and respiratory samples. The goal was to see if these devices could be accurate, fast, and cheap alternatives to standard lab tests. Researchers enrolled 149 adults with or without SARS-CoV-2, Pseudomonas aeruginosa, or Leishmania infantum infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Nanobiotechnology platforms (biosensors using molecular probes or bacteriophages)
- What this could lead to
- If successful, these biosensors could provide fast, low-cost diagnosis for infections like COVID-19, Pseudomonas, and Leishmania, especially in low-resource settings.
- What could go wrong
- This is a completed early-stage feasibility study with 149 participants. The results may not confirm real-world accuracy, and the technology may not be scalable or reliable across different settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTION VIRAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Medical and Surgical Sciences, University of Bologna
Bologna, Bologna, 40138, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can High-Dose amoxicillin be made safer?
- Can a digital swab test tell COVID and flu apart at home?
- Sniffing your way back: does scent therapy rebuild COVID-Shattered smell?
- Can a simple shot under the skin replace an IV for a key antibiotic in the elderly?
- Experimental malaria vaccine aims to block parasite growth
- Blood cancer patients may need higher antibiotic doses to beat superbugs